<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    17846141
   </pmid>
   <datecreated>
    <year>
     2007
    </year>
    <month>
     10
    </month>
    <day>
     22
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2008
    </year>
    <month>
     01
    </month>
    <day>
     15
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2009
    </year>
    <month>
     11
    </month>
    <day>
     18
    </day>
   </daterevised>
   <article pubmodel="Print-Electronic">
    <journal>
     <issn issntype="Print">
      0066-4804
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       51
      </volume>
      <issue>
       11
      </issue>
      <pubdate>
       <year>
        2007
       </year>
       <month>
        Nov
       </month>
      </pubdate>
     </journalissue>
     <title>
      Antimicrobial agents and chemotherapy
     </title>
     <isoabbreviation>
      Antimicrob. Agents Chemother.
     </isoabbreviation>
    </journal>
    <articletitle>
     Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.
    </articletitle>
    <pagination>
     <medlinepgn>
      4044-8
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      Empirical use of beta-lactam antibiotics, the preferred agents for treating uncomplicated skin and soft tissue infections, may no longer be appropriate for these infections because of the increasing prevalence of community strains of methicillin-resistant Staphylococcus aureus (MRSA). Retrospective studies, however, suggest that outcomes are good even when beta-lactams are used. We conducted a randomized, double-blind trial of 166 outpatient subjects comparing placebo to cephalexin at 500 mg orally four times for 7 days after incision and drainage of skin and soft tissue abscesses. The primary outcome was clinical cure or failure 7 days after incision and drainage. S. aureus was isolated from 70.4% of abscess cultures. Of the isolates tested 87.8% were MRSA, 93% of which were positive for Panton-Valentine leucocidin genes. Clinical cure rates were 90.5% (95% confidence interval, 0.82 to 0.96) in the 84 placebo recipients and 84.1% (95% confidence interval, 0.74 to 0.91) in the 82 cephalexin recipients (difference in the two proportions, 0.0006; 95% confidence interval, -0.0461 to 0.0472; P = 0.25). The 90.5% cure rate observed in the placebo arm and 84.1% cure rate observed in the cephalexin arm provide strong evidence that antibiotics may be unnecessary after surgical drainage of uncomplicated skin and soft tissue abscesses caused by community strains of MRSA.
     </abstracttext>
    </abstract>
    <affiliation>
     Department of Dermatology, University of California, San Francisco, San Francisco, CA 94143-0807, USA.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Rajendran
      </lastname>
      <forename>
       Priya M
      </forename>
      <initials>
       PM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Young
      </lastname>
      <forename>
       David
      </forename>
      <initials>
       D
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Maurer
      </lastname>
      <forename>
       Toby
      </forename>
      <initials>
       T
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Chambers
      </lastname>
      <forename>
       Henry
      </forename>
      <initials>
       H
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Perdreau-Remington
      </lastname>
      <forename>
       Francoise
      </forename>
      <initials>
       F
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Ro
      </lastname>
      <forename>
       Peter
      </forename>
      <initials>
       P
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Harris
      </lastname>
      <forename>
       Hobart
      </forename>
      <initials>
       H
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <grantlist completeyn="Y">
     <grant>
      <grantid>
       5-M01-RR00083
      </grantid>
      <acronym>
       RR
      </acronym>
      <agency>
       NCRR NIH HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
     <grant>
      <grantid>
       R01/CCR923381
      </grantid>
      <agency>
       PHS HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
    </grantlist>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
     <publicationtype>
      Research Support, N.I.H., Extramural
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, P.H.S.
     </publicationtype>
    </publicationtypelist>
    <articledate datetype="Electronic">
     <year>
      2007
     </year>
     <month>
      09
     </month>
     <day>
      10
     </day>
    </articledate>
   </article>
   <medlinejournalinfo>
    <country>
     United States
    </country>
    <medlineta>
     Antimicrob Agents Chemother
    </medlineta>
    <nlmuniqueid>
     0315061
    </nlmuniqueid>
    <issnlinking>
     0066-4804
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Anti-Bacterial Agents
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      15686-71-2
     </registrynumber>
     <nameofsubstance>
      Cephalexin
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Chest. 1999 Mar;115(3 Suppl):3S-8S
     </refsource>
     <pmid version="1">
      10084452
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 1999 Nov;29(5):1128-32
     </refsource>
     <pmid version="1">
      10524952
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Am J Emerg Med. 1998 Jul;16(4):343-5
     </refsource>
     <pmid version="1">
      9672446
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Saudi Med J. 2000 Dec;21(12):1125-9
     </refsource>
     <pmid version="1">
      11360084
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Surg. 2002 Nov;137(11):1217-22
     </refsource>
     <pmid version="1">
      12413304
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Antimicrob Chemother. 2002 Dec;50(6):805-10
     </refsource>
     <pmid version="1">
      12460997
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 2003 Jan 15;36(2):131-9
     </refsource>
     <pmid version="1">
      12522744
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Curr Opin Infect Dis. 2003 Apr;16(2):103-24
     </refsource>
     <pmid version="1">
      12734443
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 2003 Nov 15;37(10):1384-8
     </refsource>
     <pmid version="1">
      14583874
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      JAMA. 2003 Dec 10;290(22):2976-84
     </refsource>
     <pmid version="1">
      14665659
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pediatr Infect Dis J. 2003 Dec;22(12):1143-51
     </refsource>
     <pmid version="1">
      14688589
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pediatr Infect Dis J. 2004 Feb;23(2):123-7
     </refsource>
     <pmid version="1">
      14872177
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Microbiol. 2004 May;42(5):2080-4
     </refsource>
     <pmid version="1">
      15131173
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Surg. 2004 Sep;139(9):947-51; discussion 951-3
     </refsource>
     <pmid version="1">
      15381611
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Infect Dis. 2004 Nov 15;190(10):1730-8
     </refsource>
     <pmid version="1">
      15499526
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Pharmacotherapy. 2004 Dec;24(12 Pt 2):203S-15S
     </refsource>
     <pmid version="1">
      15585450
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Emerg Med. 2005 Mar;45(3):311-20
     </refsource>
     <pmid version="1">
      15726056
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 2005 Apr 7;352(14):1436-44
     </refsource>
     <pmid version="1">
      15814879
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 2005 Apr 7;352(14):1445-53
     </refsource>
     <pmid version="1">
      15814880
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 2005 Jun 1;40(11):1601-7
     </refsource>
     <pmid version="1">
      15889357
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Antimicrob Agents Chemother. 2005 Jun;49(6):2260-6
     </refsource>
     <pmid version="1">
      15917519
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Clin Infect Dis. 2005 Nov 15;41(10):1407-15
     </refsource>
     <pmid version="1">
      16231250
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Antimicrob Agents Chemother. 2005 Nov;49(11):4658-66
     </refsource>
     <pmid version="1">
      16251309
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Lancet. 2006 Mar 4;367(9512):731-9
     </refsource>
     <pmid version="1">
      16517273
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      N Engl J Med. 2006 Aug 17;355(7):666-74
     </refsource>
     <pmid version="1">
      16914702
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Emerg Med. 1985 Jan;14(1):15-9
     </refsource>
     <pmid version="1">
      3880635
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      J Fam Pract. 2008 May;57(5):305
     </refsource>
     <pmid version="1">
      18464334
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="CommentIn">
     <refsource>
      Expert Rev Anti Infect Ther. 2008 Feb;6(1):9-13
     </refsource>
     <pmid version="1">
      18251659
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Abscess
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      pathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Anti-Bacterial Agents
     </descriptorname>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Cephalexin
     </descriptorname>
     <qualifiername majortopicyn="Y">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Community-Acquired Infections
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      microbiology
     </qualifiername>
     <qualifiername majortopicyn="N">
      pathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Double-Blind Method
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      Methicillin Resistance
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Microbial Sensitivity Tests
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Staphylococcal Infections
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      pathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Staphylococcal Skin Infections
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="N">
      pathology
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Staphylococcus aureus
     </descriptorname>
     <qualifiername majortopicyn="Y">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Treatment Outcome
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC2151464
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="aheadofprint">
     <year>
      2007
     </year>
     <month>
      9
     </month>
     <day>
      10
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2007
     </year>
     <month>
      9
     </month>
     <day>
      12
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2008
     </year>
     <month>
      1
     </month>
     <day>
      16
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2007
     </year>
     <month>
      9
     </month>
     <day>
      12
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     AAC.00377-07
    </articleid>
    <articleid idtype="doi">
     10.1128/AAC.00377-07
    </articleid>
    <articleid idtype="pubmed">
     17846141
    </articleid>
    <articleid idtype="pmc">
     PMC2151464
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

